TONYA SAUERS: Open Payments
NPI 1750852067 · HOT SPRINGS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,222 in 74 payments from 11 companies in 2025. Trend: 2023 $328 · 2024 $558 · 2025 $1,222
Food & beverage: $1,222
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 27 | $343 |
| ABBVIE INC. | 16 | $314 |
| Otsuka America Pharmaceutical, Inc. | 14 | $200 |
| Teva Pharmaceuticals USA, Inc. | 6 | $134 |
| Lundbeck LLC | 4 | $72 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Alkermes, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $20 |
Products named: Qelbree, REXULTI, VRAYLAR, MAVYRET, AUSTEDO XR, ABILIFY ASIMTUFII, FANAPT, UZEDY.
Industry payments across AR — which companies pay providers there.
